SCHEMBL17876237

SCHEMBL17876237

c1ccc(N2Cc3cc(-c4ccc5c(c4)oc4ccccc45)ccc3-c3cc(-c4cccc5oc6ccccc6c45)ccc3C2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 6/20 0.40
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
ATM Q13315 1/20 0.34
TSHR P16473 1/20 0.33
ALOX5 P09917 1/20 0.33
PTGER4 P35408 1/20 0.33
HCRTR1 O43613 1/20 0.33
MAPT P10636 2/20 0.32
AHR P35869 1/20 0.32
BACE1 P56817 1/20 0.31
FAAH O00519 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
PRMT5 O14744 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876252 1.00 PRKDC (0.40) PRKDCNPC1RAB9AMMP12MMP13
SCHEMBL17876299 0.96 PRKDC (0.42) PRKDCNPC1RAB9AMMP12MMP13
SCHEMBL17876253 0.95 MAPT (0.35) PRKDCNPC1RAB9ATSHRALOX5
SCHEMBL17876244 0.94 PRKDC (0.34) PRKDCNPC1RAB9ATSHRALOX5
SCHEMBL17876250 0.94 PRKDC (0.34) PRKDCNPC1RAB9ATSHRALOX5
SCHEMBL17876236 0.92 NPC1 (0.38) PRKDCNPC1RAB9AMMP12MMP13
SCHEMBL17876261 0.92 PRKDC (0.37) PRKDCNPC1RAB9AALOX5MAPT
SCHEMBL17876254 0.92 PRKDC (0.37) PRKDCNPC1RAB9AALOX5MAPT
SCHEMBL17876251 0.91 ALOX5 (0.45) PRKDCATMTSHRALOX5HCRTR1
SCHEMBL17876233 0.91 ALOX5 (0.45) PRKDCATMTSHRALOX5HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PRKDC 4858/4885NPC1 2673/4885RAB9A 2843/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PRKDC 4858/4885NPC1 2673/4885RAB9A 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.